In vitro kinetics and quantitative in vitro-in vivo extrapolation of nephrotoxicants

被引：0
|
作者：
Kramer, N. [1 ]
Taverne, F. [1 ]
Mally, A. [2 ]
Jarzina, S. [2 ]
Birk, B. [3 ]
DiFiore, S. [4 ]
Ellinger, B. [5 ]
Gehring, R. [1 ]
机构：
[1] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands
[2] Univ Wurzburg, Dept Toxicol, Wurzburg, Germany
[3] BASF, Expt Toxicol & Ecol, Ludwigshafen, Germany
[4] Fraunhofer Inst Mol Biol & Appl Ecol, Div Mol Biotechnol, Aachen, Germany
[5] Fraunhofer Inst Mol Biol & Appl Ecol, Div Translat Med, Hamburg, Germany
来源：
TOXICOLOGY LETTERS | 2018年 / 295卷
关键词：
D O I：
10.1016/j.toxlet.2018.06.711
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
P08-15
引用
收藏
页码：S137 / S137
页数：1
相关论文
共 50 条
  • [1] In vitro kinetics in quantitative in vitro-in vivo extrapolation
    Kramer, Nynke I.
    TOXICOLOGY LETTERS, 2016, 258 : S4 - S4
  • [2] Evaluating In Vitro-In Vivo Extrapolation of Toxicokinetics
    Wambaugh, John F.
    Hughes, Michael F.
    Ring, Caroline L.
    MacMillan, Denise K.
    Ford, Jermaine
    Fennell, Timothy R.
    Black, Sherry R.
    Snyder, Rodney W.
    Sipes, Nisha S.
    Wetmore, Barbara A.
    Westerhout, Joost
    Setzer, R. Woodrow
    Pearce, Robert G.
    Simmons, Jane Ellen
    Thomas, Russell S.
    TOXICOLOGICAL SCIENCES, 2018, 163 (01) : 152 - 169
  • [3] Quantitative Prediction of Glucuronidation in Humans Using the In Vitro-In Vivo Extrapolation Approach
    Wu, Baojian
    Dong, Dong
    Hu, Ming
    Zhang, Shuxing
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (11) : 1343 - 1352
  • [4] Complexities of glucuronidation affecting in vitro-in vivo extrapolation
    Lin, JH
    Wong, BK
    CURRENT DRUG METABOLISM, 2002, 3 (06) : 623 - 646
  • [5] Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part II: Mechanistic Models and In Vitro-In Vivo Extrapolation
    Scotcher, Daniel
    Jones, Christopher
    Posada, Maria
    Galetin, Aleksandra
    Rostami-Hodjegan, Amin
    AAPS JOURNAL, 2016, 18 (05): : 1082 - 1094
  • [6] Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part II: Mechanistic Models and In Vitro-In Vivo Extrapolation
    Daniel Scotcher
    Christopher Jones
    Maria Posada
    Aleksandra Galetin
    Amin Rostami-Hodjegan
    The AAPS Journal, 2016, 18 : 1082 - 1094
  • [7] Importance of in vitro conditions for modeling the in vivo dose in humans by in vitro-in vivo extrapolation (IVIVE)
    Algharably, Engi Abdel Hady
    Kreutz, Reinhold
    Gundert-Remy, Ursula
    ARCHIVES OF TOXICOLOGY, 2019, 93 (03) : 615 - 621
  • [8] Using in Vitro-In Vivo Extrapolation to Predict Human Clearance
    Wang X.
    Wang, Xiangling, 1600, Mary Ann Liebert Inc. (41): : 78 - 79
  • [9] Transporter-based in vitro-in vivo extrapolation (IVIVE)
    Lukacova, Viera
    Bolger, Michael B.
    Woltosz, Walter
    Parrott, Neil
    Poirier, Agnes
    Lave, Thierry
    DRUG METABOLISM REVIEWS, 2011, 43 : 210 - 211
  • [10] Cellular Metabolism in High-Throughput In Vitro Reporter Gene Assays and Implications for the Quantitative In Vitro-In Vivo Extrapolation
    Fischer, Fabian C.
    Abele, Cedric
    Henneberger, Luise
    Kluver, Nils
    Konig, Maria
    Muhlenbrink, Marie
    Schlichting, Rita
    Escher, Beate, I
    CHEMICAL RESEARCH IN TOXICOLOGY, 2020, 33 (07) : 1770 - 1779
12345